• Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Rating of "Moderate Buy" by Brokerages

    来源: Buzz FX / 04 3月 2025 02:52:12   America/New_York


    Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Rating of "Moderate Buy" by Brokerages Written by MarketBeat March 4, 2025 Share Link copied to clipboard. Shares of Halozyme Therapeutics, Inc. ( NASDAQ:HALO - Get Free Report ) have
    Read more...
分享